Abiopharma

Yu Yongkang 🟡 adjusted position in 725.1K shares (6 derivative) of DDC Enterprise Ltd (DDC) at $5.50 Transaction Date: Mar 20, 2026 | Filing ID: 049711

New Form SCHEDULE 13G - Intellia Therapeutics, Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0002100119-26-000581 <b>Size:</b> 7 KB

New Form SCHEDULE 13G - Howmet Aerospace Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0002100119-26-000582 <b>Size:</b> 7 KB

New Form SCHEDULE 13G - GoDaddy Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0002100119-26-000577 <b>Size:</b> 7 KB

New Form SCHEDULE 13G - Hewlett Packard Enterprise Co <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0002100119-26-000579 <b>Size:</b> 7 KB

New Form SCHEDULE 13G - HOULIHAN LOKEY, INC. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0002100119-26-000578 <b>Size:</b> 7 KB

New Form SCHEDULE 13G - Ingevity Corp <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0002100119-26-000580 <b>Size:</b> 7 KB

General Announcement: Trendlines Monthly Update - April 2026

Director Lai Kwok Ho 🟡 adjusted position in 191.1K shares (5 derivative) of DDC Enterprise Ltd (DDC) at $5.50 Transaction Date: Mar 20, 2026 | Filing ID: 049708

Director Shih Samuel Chun Kong 🟡 adjusted position in 191.1K shares (5 derivative) of DDC Enterprise Ltd (DDC) at $5.50 Transaction Date: Mar 20, 2026 | Filing ID: 049706